Despite increasing cure rates for pediatric leukemia, relapsed disease still carries a poor prognosis with significant morbidity and mortality. cells. BiTE antibodies show great promise as a novel and effective therapy for childhood leukemia. This review will Belnacasan outline recent developments in targeted agents for pediatric Ywhaz leukemia including monoclonal antibodies, ADCs, and BiTE antibodies.… Continue reading Despite increasing cure rates for pediatric leukemia, relapsed disease still carries